Pharmacology of Calcium Metabolism

Drugs used to treat Hypocalcemia

Calcium Salts -

  • Calcium Carbonate
  • Calcium Citrate
  • Calcium Lactate
  • Calcium gluconate

Ø  use with caution in patients on Digitalis

Vitamin D preparations

  • drugs of choice for treatment of Chronic hypocalcemia
  • several preps
  • DHT – dihydrotachysterol

Ø  duration of action – 2 weeks

Ø  requires liver and kidney for metabolism

Ø  $20/week

  • 25-(OH)-D3 – calcifediol

Ø  duration of action – 2-3 weeks

Ø  require kidney for metabolism

Ø  t1/2= 20 hrs

Ø  $10/week

  • 1,25-(OH)2 – D3 – calcitriol

Ø  quick time to max effect (3 min)

Ø  duration of action – 3-5 days

Ø  no requirements for metabolism

Ø  t1/2= 15 hrs

Ø  $45/week

  • plain old D2 or D3

Ø  requires liver or kidney for metabolism

Ø  duration of action – 2 mths

Ø  time to max effect – 4 weeks

Ø  t1/2= 30

Ø  $1/week

Thiazide Diuretics

Drugs to treat Hypercalcemia

Calcitonin

  • useful in high doses for Paget’s disease treatment
  • tolerance develops
  • hypersecretion of PTH

Glucocorticoids

  • major effect is on gut to reduce Ca2+ absorption

Furosemide

  • administer with IV saline to insure adequate hydration

Bisphonates – sodium etidronate, alendronate

  • analogues of pyrophosphate which bind directly to hydroxyapatite crystals in bone and impair resorption
  • 50% of absorbed drug is bound to bone.
  • Actually decreases both formation and resorption; net effect – decreased bone resorption
  • Uses: Paget’s Disease, benign or malignant neoplasms, trauma, osteoporosis
  • Adverse effects: GI disturbances (including GI bleeding)

Mithramycin

  • 2nd line agent for Paget’s disease and hypercalcemia
  • inhibits RNA synthesis; proteins are needed for bone resorption
  • Toxic at high doses to rapidly proliferating cells

Fluoride

  • may stimulate bone formation in the presence of Ca without affecting bone resorption
  • forms abnormal crystal- less mechanical strength.

Drugs used to treat Osteoporosis

Ca2+ supplementation

Low dose Vitamin D

Estrogens

Alendronate

Calcitonin

Sodium Fluoride

SERMS – (Raloxifene)

  • tissue specific effects
  • Raloxifene is estrogen receptor AGONIST in the bone and the liver
  • ANTAGONIST in the uterus and brain
  • Actions

Ø  decreases rate of bone loss

Ø  decreases LDL

Ø  Side effect: increases post-menopausal symptoms

Exercise

Tags: , , , , , , , , ,